Clinical Trials on Nutrient; Excess in Canada
Total 19 results
-
Clinical Evaluation Research Unit at Kingston General...UnknownCardiovascular Diseases | Aging | Nutrient; ExcessCanada
-
The Hospital for Sick ChildrenRare Disease Foundation Microgrant competitionCompleted
-
McMaster UniversityHamilton Health Sciences CorporationRecruitingCeliac Disease | Nutrient DeficiencyCanada
-
Lawson Health Research InstituteCompletedRenal Function | Gastrointestinal Microbiome, Atherosclerosis, NutrientsCanada
-
University of SaskatchewanCompleted
-
Queen's UniversityUnknownDifficult IV AccessCanada
-
Centre hospitalier de l'Université de Montréal...CompletedCentral Venous Catheter | Vascular Access DevicesCanada
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); Ontario Ministry of Health and...Completed
-
Lawson Health Research InstituteNot yet recruitingMedical Devices | Open Access | Low Cost | ElectrocardiographCanada
-
Sunnybrook Health Sciences CentreNot yet recruitingPeritoneal Dialysis Complication | Peritoneal Dialysis Access FailureCanada
-
Hamilton Health Sciences CorporationLondon Health Sciences CentreCompletedRenal Insufficiency, Chronic | Zinc Deficiency | Trace Element Excess | Trace Element DeficiencyCanada
-
The University of QueenslandAustralasian Kidney Trials NetworkActive, not recruitingVascular Access Complication | Hemodialysis Access Failure (Disorder)Netherlands, Switzerland, Canada, France, United Kingdom, Australia, Malaysia
-
Onconova Therapeutics, Inc.TerminatedMyelodysplastic Syndrome | MDS | Refractory Anemia With Excess Blasts | RAEBUnited States, Spain, Canada, France, Australia, Switzerland, Israel, Japan, Belgium, India, Ireland, United Kingdom, Croatia, Czechia, Poland, Estonia, Germany, Italy, Austria, Hungary, Russian Federation, Sweden
-
Terumo Medical CorporationMontreal Heart InstituteCompletedVascular Access ComplicationCanada
-
National Cancer Institute (NCI)RecruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Myeloproliferative NeoplasmUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Chronic Myelomonocytic Leukemia-1 | Chronic Myelomonocytic Leukemia-2 | Myelodysplastic Syndrome With Excess Blasts-1 | Myelodysplastic Syndrome/Acute Myeloid LeukemiaCanada, United States
-
Women's College HospitalCompleted
-
Lawson Health Research InstituteWestern University, CanadaCompletedEnd Stage Renal Disease | Chronic Lung Disease | Dyspnea; Uremic | Chronic Heart Disease | Hemodialysis-Induced Symptom | Sodium ExcessCanada
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRecruitingLong Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramUnited States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France